Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 18

1.

Small ncRNA-Seq Results of Human Tissues: Variations Depending on Sample Integrity.

Ludwig N, Fehlmann T, Galata V, Franke A, Backes C, Meese E, Keller A.

Clin Chem. 2018 Apr 24. pii: clinchem.2017.285767. doi: 10.1373/clinchem.2017.285767. [Epub ahead of print]

PMID:
29691221
2.

Gene amplification in mesenchymal stem cells and during differentiation towards adipocytes or osteoblasts.

Altmayer NC, Galata V, Warschburger N, Keller A, Meese E, Fischer U.

Oncotarget. 2017 Dec 1;9(2):1803-1812. doi: 10.18632/oncotarget.22804. eCollection 2018 Jan 5.

3.

Which Language R You Speaking? /r/ as a Language Marker in Tyrolean and Italian Bilinguals.

Kaland C, Galatà V, Spreafico L, Vietti A.

Lang Speech. 2017 Dec 1:23830917746551. doi: 10.1177/0023830917746551. [Epub ahead of print]

PMID:
29233049
4.

Assessing the heterogeneity of in silico plasmid predictions based on whole-genome-sequenced clinical isolates.

Laczny CC, Galata V, Plum A, Posch AE, Keller A.

Brief Bioinform. 2017 Dec 5. doi: 10.1093/bib/bbx162. [Epub ahead of print]

PMID:
29220507
5.

BusyBee Web: metagenomic data analysis by bootstrapped supervised binning and annotation.

Laczny CC, Kiefer C, Galata V, Fehlmann T, Backes C, Keller A.

Nucleic Acids Res. 2017 Jul 3;45(W1):W171-W179. doi: 10.1093/nar/gkx348.

6.

miRNAs in Ancient Tissue Specimens of the Tyrolean Iceman.

Keller A, Kreis S, Leidinger P, Maixner F, Ludwig N, Backes C, Galata V, Guerriero G, Fehlmann T, Franke A, Meder B, Zink A, Meese E.

Mol Biol Evol. 2017 Apr 1;34(4):793-801. doi: 10.1093/molbev/msw291.

PMID:
28025275
7.

Comparing genome versus proteome-based identification of clinical bacterial isolates.

Galata V, Backes C, Laczny CC, Hemmrich-Stanisak G, Li H, Smoot L, Posch AE, Schmolke S, Bischoff M, von Müller L, Plum A, Franke A, Keller A.

Brief Bioinform. 2018 May 1;19(3):495-505. doi: 10.1093/bib/bbw122.

PMID:
28013236
8.

Deep characterization of blood cell miRNomes by NGS.

Schwarz EC, Backes C, Knörck A, Ludwig N, Leidinger P, Hoxha C, Schwär G, Grossmann T, Müller SC, Hart M, Haas J, Galata V, Müller I, Fehlmann T, Eichler H, Franke A, Meder B, Meese E, Hoth M, Keller A.

Cell Mol Life Sci. 2016 Aug;73(16):3169-81. doi: 10.1007/s00018-016-2154-9. Epub 2016 Feb 13.

PMID:
26874686
9.

Validating Alzheimer's disease micro RNAs using next-generation sequencing.

Keller A, Backes C, Haas J, Leidinger P, Maetzler W, Deuschle C, Berg D, Ruschil C, Galata V, Ruprecht K, Stähler C, Würstle M, Sickert D, Gogol M, Meder B, Meese E.

Alzheimers Dement. 2016 May;12(5):565-76. doi: 10.1016/j.jalz.2015.12.012. Epub 2016 Jan 22.

PMID:
26806387
10.

High-throughput qRT-PCR validation of blood microRNAs in non-small cell lung cancer.

Leidinger P, Brefort T, Backes C, Krapp M, Galata V, Beier M, Kohlhaas J, Huwer H, Meese E, Keller A.

Oncotarget. 2016 Jan 26;7(4):4611-23. doi: 10.18632/oncotarget.6566.

11.

Prioritizing and selecting likely novel miRNAs from NGS data.

Backes C, Meder B, Hart M, Ludwig N, Leidinger P, Vogel B, Galata V, Roth P, Menegatti J, Grässer F, Ruprecht K, Kahraman M, Grossmann T, Haas J, Meese E, Keller A.

Nucleic Acids Res. 2016 Apr 7;44(6):e53. doi: 10.1093/nar/gkv1335. Epub 2015 Dec 3.

12.

Influence of next-generation sequencing and storage conditions on miRNA patterns generated from PAXgene blood.

Backes C, Leidinger P, Altmann G, Wuerstle M, Meder B, Galata V, Mueller SC, Sickert D, Stähler C, Meese E, Keller A.

Anal Chem. 2015 Sep 1;87(17):8910-6. doi: 10.1021/acs.analchem.5b02043. Epub 2015 Aug 10.

PMID:
26207298
13.

Longitudinal study on circulating miRNAs in patients after lung cancer resection.

Leidinger P, Galata V, Backes C, Stähler C, Rheinheimer S, Huwer H, Meese E, Keller A.

Oncotarget. 2015 Jun 30;6(18):16674-85.

14.

Posttranscriptional deregulation of signaling pathways in meningioma subtypes by differential expression of miRNAs.

Ludwig N, Kim YJ, Mueller SC, Backes C, Werner TV, Galata V, Sartorius E, Bohle RM, Keller A, Meese E.

Neuro Oncol. 2015 Sep;17(9):1250-60. doi: 10.1093/neuonc/nov014. Epub 2015 Feb 13.

15.

miRNAs can be generally associated with human pathologies as exemplified for miR-144.

Keller A, Leidinger P, Vogel B, Backes C, ElSharawy A, Galata V, Mueller SC, Marquart S, Schrauder MG, Strick R, Bauer A, Wischhusen J, Beier M, Kohlhaas J, Katus HA, Hoheisel J, Franke A, Meder B, Meese E.

BMC Med. 2014 Dec 3;12:224. doi: 10.1186/s12916-014-0224-0.

16.

What makes a blood cell based miRNA expression pattern disease specific?--a miRNome analysis of blood cell subsets in lung cancer patients and healthy controls.

Leidinger P, Backes C, Dahmke IN, Galata V, Huwer H, Stehle I, Bals R, Keller A, Meese E.

Oncotarget. 2014 Oct 15;5(19):9484-97.

17.

Secretion and immunogenicity of the meningioma-associated antigen TXNDC16.

Harz C, Ludwig N, Lang S, Werner TV, Galata V, Backes C, Schmitt K, Nickels R, Krause E, Jung M, Rettig J, Keller A, Menger M, Zimmermann R, Meese E.

J Immunol. 2014 Sep 15;193(6):3146-54. doi: 10.4049/jimmunol.1303098. Epub 2014 Aug 13.

18.

Towards a protocol in speaker recognition analysis.

Romito L, Galatà V.

Forensic Sci Int. 2004 Dec 2;146 Suppl:S107-11.

PMID:
15639553

Supplemental Content

Loading ...
Support Center